Gelonghui April 25丨Yifang Biotech (688382.SH) released its 2023 annual report. During the reporting period, the company made every effort to promote clinical research and cooperative development of major products and made important progress. In 2023, it achieved operating income of 186 million. Yuan, the net profit attributable to shareholders of listed companies was -284 million yuan, a year-on-year loss reduction of 41.26%, and the loss margin narrowed compared with the same period last year, mainly due to the increase in the company\’s technology licensing and technical cooperation income in 2023.
Yifang Biological (688382.SH): Net profit in 2023 -284 million yuan
Gelonghui April 25丨Yifang Biotech (688382.SH) released its 2023 annual report. During the reporting period, the company made every effort to promote clinical research and cooperative development of major products and made important progress. In 2023, it achieved operating income of 186 million. Yuan, the net profit attributable to shareholders of listed companies was -284 million yuan, a year-on-year loss reduction of 41.26%, and the loss margin narrowed compared with the same period last year, mainly due to the increase in the company\’s technology licensing and technical cooperation income in 2023.
Like (0)
Neway CNC (688697.SH): Net profit in the first quarter was 69.5514 million yuan, a year-on-year decrease of 3.03%
Previous
April 25, 2024 7:59 pm